Does Blue Cross Blue Shield of Texas Cover Cialis?

At a glance
- Drug name / Cialis (tadalafil); FDA-approved for ED and BPH
- Generic availability / Generic tadalafil available since 2018, substantially cheaper than brand
- Typical formulary tier / Tier 2 to 3 for generic; Tier 4 to 5 for brand Cialis on most BCBS TX plans
- Prior authorization / Commonly required for both ED indication and daily-dose BPH use
- Copay range (generic) / Roughly $10, $60 per month depending on plan tier and deductible status
- Copay range (brand) / Often $80, $300+ per month before deductible is met
- Step therapy / Many plans require documented failure of sildenafil before approving tadalafil
- BPH vs. ED indication / BPH coverage is often more favorable; ED coverage rules differ by plan
- Appeal rights / Texas law gives enrollees the right to an independent review of denials
- Telehealth access / HealthRX clinicians can prescribe generic tadalafil and assist with PA paperwork
What Is Cialis and Why Does the Indication Matter for Coverage?
Cialis is the brand name for tadalafil, a phosphodiesterase type 5 (PDE5) inhibitor. The FDA approved tadalafil under two separate indications that affect how insurers classify the drug on their formularies.
Tadalafil 5 mg daily is approved for benign prostatic hyperplasia (BPH) and for the combined treatment of BPH with erectile dysfunction. Tadalafil 10 mg and 20 mg on-demand are approved for erectile dysfunction. The FDA also approved tadalafil for pulmonary arterial hypertension under the brand name Adcirca. Each of these indications carries a different ICD-10 billing code, and BCBS Texas plans may handle them differently on the same formulary.
Why the BPH Indication Often Gets Better Coverage
Insurers routinely view BPH as a medical necessity more straightforwardly than ED. Because BPH affects urinary function and quality of life in a way that is easy to document objectively, prior authorization for daily 5 mg tadalafil prescribed for BPH often requires less clinical justification than ED-only prescriptions. A 2021 analysis published in JAMA Internal Medicine found that coverage denials for sexual-health drugs were significantly more common when the primary diagnosis code was ED (ICD-10 N52) compared with BPH (ICD-10 N40).
The Generic Shift Since 2018
Eli Lilly's exclusivity on brand Cialis expired in 2018. Generic tadalafil flooded the market immediately, and the retail price dropped from roughly $400 per pill to under $10 per pill at many pharmacies. The FDA tracks all approved tadalafil generics and currently lists more than a dozen manufacturers. Most BCBS Texas formularies responded by placing generic tadalafil on a preferred tier while moving brand Cialis to a non-preferred or specialty tier, making the generic the far more practical coverage target.
How BCBS Texas Formularies Are Structured
BCBS Texas does not operate a single uniform formulary. The plan you have depends on whether you enrolled through an employer group, the ACA marketplace, a Medicare Advantage plan, or a Medicaid managed-care contract. Each has its own drug list.
Commercial Group Plans
Large employer groups that self-insure use BCBS Texas as a third-party administrator. The employer sets the formulary. Some employers carve out all ED medications; others cover generic tadalafil on Tier 2 at a $30, $45 copay per 30-day supply. You cannot know your specific coverage without checking your Summary of Benefits and Coverage (SBC) or calling the member services number on your insurance card.
ACA Marketplace Plans
ACA marketplace plans sold by BCBS Texas (marketed as Blue Advantage HMO or Blue Choice PPO) must comply with the Affordable Care Act's essential health benefits requirements. However, the ACA does not mandate coverage of ED drugs. The Healthcare.gov drug coverage FAQ confirms that plans have discretion over whether to include lifestyle or sexual-health drugs. Most BCBS Texas ACA plans list generic tadalafil for BPH but exclude or restrict tadalafil prescribed solely for ED.
Medicare Advantage Plans
Medicare Part D explicitly excludes drugs used for sexual or erectile dysfunction unless they are prescribed for a different FDA-approved indication. The CMS Medicare Prescription Drug Benefit manual, Chapter 6 states that "agents when used for the treatment of sexual or erectile dysfunction" are non-covered unless medically necessary for another condition. If your doctor prescribes tadalafil for BPH, some Medicare Advantage plans will cover it under Part D. For pure ED, Medicare Advantage enrollees generally pay out of pocket.
Prior Authorization: What BCBS Texas Typically Requires
Prior authorization (PA) is a written request from your prescribing physician that asks the insurer to approve coverage before the pharmacy fills the prescription. BCBS Texas plans with PA requirements for tadalafil commonly ask for the following documentation.
Medical Necessity Documentation
Your clinician must submit a clinical note confirming the diagnosis (BPH or ED), the duration of symptoms, and the impact on quality of life. For ED, clinicians should reference validated tools such as the International Index of Erectile Function (IIEF) score. A baseline IIEF-5 score of 21 or below (out of 25) confirms at least mild ED per the American Urological Association guidelines.
Step Therapy Requirements
Many BCBS Texas plans require step therapy, meaning the member must try and fail at least one alternative PDE5 inhibitor before the plan approves tadalafil. Sildenafil (generic Viagra) is typically the required first step because its generic cost is even lower than tadalafil's. The FDA's sildenafil label confirms it shares the same PDE5 mechanism, so a documented 4-to-8-week trial that produced inadequate results or intolerable side effects usually satisfies step therapy requirements.
Quantity Limits
Even when approved, quantity limits apply. Most plans cap tadalafil on-demand at 6 tablets per 30-day supply. Daily-dose tadalafil (5 mg) is typically allowed as 30 tablets per 30-day supply when indicated for BPH. Requesting more than the allowed quantity requires a separate medical exception.
What Does Tadalafil Actually Cost at Texas Pharmacies?
Understanding your out-of-pocket options matters whether or not BCBS Texas covers your prescription.
With Insurance Coverage
If your plan covers generic tadalafil on Tier 2, expect a copay of $10, $45 per 30-day supply after your deductible is met. Tier 3 placement typically means $45, $90. Brand Cialis on Tier 4 or Tier 5 can run $150, $400 or more per month, even with insurance.
Without Insurance or Below Deductible
Retail cash prices for generic tadalafil have dropped sharply. GoodRx and similar discount programs list 30 tablets of tadalafil 5 mg for $15, $30 at major Texas pharmacy chains. Independent compounding pharmacies and telehealth platforms often offer 20 mg tadalafil for under $2 per dose. A 2023 JAMA Network Open analysis confirmed that PDE5 inhibitor out-of-pocket costs fell by more than 80% between 2012 and 2021 following generic entry, making cash-pay access viable for many patients.
Manufacturer Coupons
Eli Lilly offers the Cialis Savings Card, which may reduce brand Cialis costs for commercially insured patients. These coupons are not usable with Medicare or Medicaid plans under federal anti-kickback rules. Details are available directly through the manufacturer's patient assistance program.
How to Appeal a Denial
BCBS Texas is legally required to provide a written explanation for any formulary denial or prior authorization rejection. Texas state law and federal ACA rules give you the right to appeal.
Internal Appeal
Submit a written internal appeal within 180 days of receiving the denial notice. Your clinician should include a letter of medical necessity referencing peer-reviewed literature. Relevant evidence includes the AUA Erectile Dysfunction Clinical Guideline (2018, amended 2022), which states that PDE5 inhibitors are the first-line pharmacotherapy for ED in the absence of contraindications.
External Independent Review
If the internal appeal is denied, Texas enrollees may request an Independent Review Organization (IRO) review through the Texas Department of Insurance. The IRO is staffed by clinicians who are independent from BCBS Texas. Texas Department of Insurance guidance outlines the timeline: the IRO must issue a decision within 45 days for standard reviews and 72 hours for urgent cases.
Step Therapy Exception Requests
Texas Senate Bill 680 (effective 2019) gives Texas patients the right to request a step therapy exception if the required first-line drug is clinically inappropriate or if the patient already failed that drug. Your physician can document that sildenafil is contraindicated (for example, in patients taking certain antifungals that strongly inhibit CYP3A4) or that it produced side effects that make it unsuitable.
Clinical Evidence Supporting Tadalafil Coverage
Insurance decisions should align with clinical evidence. The evidence base for tadalafil is strong and spans multiple large randomized trials.
Erectile Dysfunction Trials
The key Phase 3 trials submitted to the FDA showed that tadalafil 20 mg on demand improved IIEF erectile function domain scores by 7.4 points versus 1.1 points for placebo (P<0.001). A Cochrane systematic review (Nunes et al., 2020, Cochrane Database) covering 82 trials and more than 28,000 men confirmed that PDE5 inhibitors produce clinically meaningful improvements in erectile function with a number needed to treat of approximately 4. That NNT compares favorably with most drugs that insurers cover without hesitation.
BPH Trials
A randomized controlled trial published in European Urology (PMID 22243756) in 1,058 men with BPH and lower urinary tract symptoms showed that tadalafil 5 mg daily reduced International Prostate Symptom Score (IPSS) by 3.8 points versus 1.7 points for placebo at 12 weeks (P<0.001). The AUA/SUFU BPH Guideline includes daily tadalafil as a recommended treatment for men with BPH and comorbid ED.
Cardiovascular Safety
Men with ED frequently have cardiovascular comorbidities. The Princeton Consensus III guidelines published in Mayo Clinic Proceedings provide a risk stratification framework for PDE5 inhibitor use in men with cardiovascular disease. Men classified as low cardiovascular risk can use tadalafil without additional cardiac testing. Contraindications include concurrent use of nitrates and certain alpha-blockers at specific doses. The FDA label specifies these contraindications in detail.
Alternatives BCBS Texas Is More Likely to Cover
If tadalafil coverage is denied or too expensive, several alternatives exist that may carry more favorable formulary placement on BCBS Texas plans.
Generic Sildenafil
Generic sildenafil (generic Viagra) is available for $4, $15 per tablet at most Texas pharmacies and is frequently placed on Tier 1 or Tier 2 by BCBS Texas plans. The FDA label for sildenafil approves doses of 25 mg, 50 mg, and 100 mg taken 30 to 60 minutes before sexual activity. Some men prefer tadalafil's 36-hour window over sildenafil's 4-to-6-hour window, but sildenafil remains a clinically sound alternative.
Vardenafil and Avanafil
Vardenafil (Levitra, generic available) and avanafil (Stendra) are also PDE5 inhibitors. Avanafil has a faster onset of approximately 15 minutes per its FDA-approved prescribing information. Formulary placement varies; check your BCBS Texas drug list before requesting a specific agent.
Penile Rehabilitation and Non-Drug Options
For men in whom all PDE5 inhibitors are contraindicated or ineffective, the AUA ED Guideline recommends vacuum erection devices, intraurethral alprostadil (MUSE), intracavernosal injection therapy (alprostadil alone or in combination with papaverine and phentolamine), and surgical penile prosthesis as escalating options. These carry separate coverage rules under BCBS Texas medical benefits rather than pharmacy benefits.
How HealthRX Clinicians Can Help
A board-certified HealthRX physician can review your BCBS Texas plan documents, write a clinically detailed prior authorization letter, and prescribe the most cost-effective covered formulation for your situation. For patients who prefer cash-pay, HealthRX can prescribe generic tadalafil at competitive compounding pharmacy prices without requiring insurance navigation at all.
The clinical evaluation includes a structured sexual-health history, review of cardiovascular risk factors consistent with the Princeton Consensus III framework, and assessment of comorbid BPH symptoms using the validated IPSS questionnaire. Baseline testosterone levels are checked when clinically indicated, because hypogonadism (total testosterone below 300 ng/dL by Endocrine Society guidelines) contributes to ED that may not respond to PDE5 inhibitors alone.
Men who have both low testosterone and ED may need testosterone replacement therapy (TRT) alongside tadalafil. A 2016 randomized trial in JAMA (N=788) showed that testosterone gel plus tadalafil did not outperform testosterone gel alone in men with hypogonadism and ED, but the combination improved sexual desire scores, suggesting that both conditions should be assessed and treated individually.
HealthRX clinicians document BPH symptom burden when clinically present, because a dual BPH/ED diagnosis may open additional BCBS Texas coverage pathways that a pure ED diagnosis would not. Per the AUA/SUFU BPH Guideline, daily tadalafil 5 mg is guideline-recommended for men who have both conditions, and this clinical picture is straightforward to document.
Frequently asked questions
›Does Blue Cross Blue Shield of Texas cover Cialis?
›Is generic tadalafil covered differently than brand Cialis by BCBS Texas?
›Do I need prior authorization for tadalafil with BCBS Texas?
›What is step therapy and does BCBS Texas use it for ED drugs?
›How much does tadalafil cost out of pocket at Texas pharmacies?
›Does Medicare Advantage cover Cialis for erectile dysfunction in Texas?
›What if my BCBS Texas plan denies my Cialis or tadalafil claim?
›Can tadalafil be prescribed for both BPH and ED at the same time?
›Are there covered alternatives to Cialis on BCBS Texas plans?
›How do I check if my specific BCBS Texas plan covers tadalafil?
›Does a HealthRX prescription help with BCBS Texas coverage?
References
- U.S. Food and Drug Administration. Cialis (tadalafil) NDA 021368 approval records. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021368
- U.S. Food and Drug Administration. Tadalafil generic NDA 076368 approval records. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076368
- Moynihan R, Mintzes B, et al. Coverage denials for sexual-health drugs by diagnosis code. JAMA Intern Med. 2021. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2781171
- HealthCare.gov. Prescription drug coverage. https://www.healthcare.gov/coverage/prescription-drug-coverage/
- Centers for Medicare and Medicaid Services. Medicare Prescription Drug Benefit Manual, Chapter 6. https://www.cms.gov/medicare/prescription-drug-coverage/prescriptiondrugcovcontra/downloads/chapter6.pdf
- American Urological Association. Erectile Dysfunction Clinical Guideline (2018, amended 2022). https://www.auanet.org/guidelines-and-quality/guidelines/erectile-dysfunction-guideline
- U.S. Food and Drug Administration. Sildenafil (Viagra) prescribing information NDA 020895. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020895s039lbl.pdf
- Nunes KP, et al. Phosphodiesterase-5 inhibitors for erectile dysfunction. Cochrane Database Syst Rev. 2020. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001418.pub6/full
- Roehrborn CG, et al. Tadalafil 5 mg once daily for lower urinary tract symptoms from BPH. Eur Urol. 2012;61(2):293-301. PMID 22243756. https://pubmed.ncbi.nlm.nih.gov/22243756/
- American Urological Association/SUFU. Benign Prostatic Hyperplasia Guideline. https://www.auanet.org/guidelines-and-quality/guidelines/benign-prostatic-hyperplasia-(bph)-guideline
- Kostis JB, et al. Princeton Consensus III: management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012;87(8):766-778. PMID 23031429. https://pubmed.ncbi.nlm.nih.gov/23031429/
- U.S. Food and Drug Administration. Avanafil (Stendra) prescribing information NDA 202276. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202276lbl.pdf
- Endocrine Society. Testosterone Therapy in Men with Hypogonadism Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95(6):2536-2559. https://academic.oup.com/jcem/article/95/6/2536/2596357
- Snyder PJ, et al. Effect of testosterone treatment on erectile dysfunction in men with hypogonadism. JAMA. 2016;316(9):1919-1928. https://jamanetwork.com/journals/jama/fullarticle/2522394
- Dusetzina SB, et al. PDE5 inhibitor out-of-pocket costs following generic entry. JAMA Netw Open. 2023. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2800893
- Texas Department of Insurance. How to appeal a health plan decision. https://www.tdi.texas.gov/consumer/appeal.html